Find a company
| Project | Development of a rapid and modular phenotypic test for quantitative Urinary Tract Infection detection and antimicrobial susceptibility in 30 minutes |
|---|---|
| Description |
The technology behind FluoCDx leverages modular DNA probes, customizable for precise species recognition and broad gram-type bacterial detection. Within 5 minutes of adding a sample, the initial fluorescence signal quantitatively confirms infection. After 30 minutes, changes in fluorescence reveal antibiotic susceptibility: an increase indicates resistance, while a decrease or stable signal confirms susceptibility. This innovative approach ensures rapid, reliable diagnostics, enabling precise treatment decisions. |
| Funding | £ 99,999 |
| Competition | Competition 25 - AMR |
| Competition Date | July 2024 |
| Categories | Antimicrobial Resistance (AMR) |
| Website | https://www.cexal.com/ |